Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease
- Conditions
- Parkinson DiseaseGait Disorders, NeurologicParkinsonismParkinsonGait, Festinating
- Registration Number
- NCT04238000
- Brief Summary
Objective of the study:
To test the efficacy of theta burst cerebellar stimulation on dual task walking in Parkinson's disease using a cross-over design and wearing sensors technology
Design:
Twenty Parkinson's disease patients with no dementia will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.
Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology .
- Detailed Description
There are no medical effective treatments for dual-task gait in Parkinson's disease. Imaging, neurophysiology and pathology studies suggested cerebellum as possible target of brain stimulation for dual-task walking for theta Burst repetitive Transcranial magnetic stimulation
Objective of the study:
To test the efficacy of theta burst cerebellar stimulation on gait in Parkinson's disease using a cross-over design and wearing sensors technology
Design:
Parkinson's disease patients able to walk and without dementia/behavioral disturbances will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.
Repetitive cerebellar theta burst stimulation will be performed by Duo-Mag XT100, using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.
A sample size of 20 subjects with complete stimulation (2 stimulations per subject, for a total number of stimulation)
Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology.
Sensors assessment:
The following gait parameters will be evaluated in normal and cognitive/motor dual-tasks:
i) step length ii) step variability iii) step phases iv) turning speed
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- established Parkinson's disease
- ability to stand alone and walk without support
- dementia or behavioral alterations
- contraindication to stimulation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Gait speed in dual-task walking Changes from Baseline to immediately after stimulation Gait speed will be assessed in normal, cognitive/motor dual-task conditions
Step length in dual-task walking Changes from Baseline to immediately after stimulation Step length will be assessed in normal, cognitive/motor dual-task conditions
Step variability in dual-task walking Changes from Baseline to immediately after stimulation Step variability will be assessed in normal, cognitive/motor dual-task conditions walking
- Secondary Outcome Measures
Name Time Method Turning speed in timed up and go tests Changes from Baseline to immediately after stimulation Turning will be assessed y wearing sensors during timed up and go tests
total distance of dual-task walking Changes from Baseline to immediately after stimulation The total distance of one minute normal/motor/cognitive dual-task walking will be assessed
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Parkinson's disease Rehabilitation Centre - FERB ONLUS
🇮🇹Trescore Balneario, Italy
Parkinson's disease Rehabilitation Centre - FERB ONLUS🇮🇹Trescore Balneario, ItalyAndrea Pilotto, MDContact3396245281pilottoandreae@gmail.comMaria Cristina Rizzetti, MDContact035 955326rizzetti@hotmail.com